AstraZeneca initiates global withdrawal of its COVID-19 vaccine due to surplus of updated vaccines, impacting marketing authorizations within Europe
Simple ethical design
AstraZeneca initiates global withdrawal of its COVID-19 vaccine due to surplus of updated vaccines, impacting marketing authorizations within Europe